Bechara R, Inoue H. Recent advancement of therapeutic endoscopy in the esophageal benign diseases. World J Gastrointest Endosc 2015; 7(5): 481-495 [PMID: 25992187 DOI: 10.4253/wjge.v7.i5.481]
Corresponding Author of This Article
Robert Bechara, HonBSc, MD, FRCPC, Digestive Diseases Center, Showa University Koto-Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-0061, Japan. bechara.robert@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Endosc. May 16, 2015; 7(5): 481-495 Published online May 16, 2015. doi: 10.4253/wjge.v7.i5.481
Recent advancement of therapeutic endoscopy in the esophageal benign diseases
Robert Bechara, Haruhiro Inoue
Robert Bechara, Haruhiro Inoue, Digestive Diseases Center, Showa University Koto-Toyosu Hospital, Koto-ku, Tokyo 135-0061, Japan
Author contributions: Bechara R and Inoue H both contributed to the writing of this paper.
Conflict-of-interest: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Robert Bechara, HonBSc, MD, FRCPC, Digestive Diseases Center, Showa University Koto-Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo 135-0061, Japan. bechara.robert@gmail.com
Telephone: +81-3-62046064 Fax: +81-3-62046998
Received: October 28, 2014 Peer-review started: November 2, 2014 First decision: December 26, 2014 Revised: January 13, 2015 Accepted: February 4, 2015 Article in press: February 9, 2015 Published online: May 16, 2015 Processing time: 201 Days and 15.5 Hours
Core Tip
Core tip: Antireflux mucosectomy is an endoscopic antireflux procedure showing promising results in patients with refractory gastroesophageal reflux. Over the scope clips and esophageal stents permit safe endoscopic closure of esophagogastric defects, decreasing the requirement for surgical intervention. Per-oral endoscopic myotomy allows the precise performance of endoscopic myotomy for the treatment of spastic esophageal motility disorders with the efficacy of a surgical myotomy without the associated surgical morbidity. Per-oral endoscopic tumor resection enables en bloc endoscopic removal of subepithelial tumors (SETs) and is both a diagnostic and therapeutic intervention for esophageal SETs. These techniques will expand the boundaries of therapeutic endoscopy, decrease the need for surgical intervention, and improve patient outcomes.
